Find similar content

Source channel @githubtrending · Post #15076 · Aug 19

#python#aws#mcp#mcp_client#mcp_clients#mcp_host#mcp_server#mcp_servers#mcp_tools#modelcontextprotocol AWS MCP Servers use the Model Context Protocol (MCP), an open standard that connects AI tools with AWS data and services in a simple, secure way. These servers improve AI responses by providing up-to-date AWS documentation, best practices, and workflow automation for cloud development, infrastructure, and operations. You can run MCP servers locally for development or use AWS-managed remote servers for easy access and scalability. MCP servers support many AWS services like Lambda, DynamoDB, EKS, and more, helping you build, manage, and optimize AWS resources efficiently with AI assistance. Installation is easy with one-click options for popular tools like VS Code and Cursor. This makes cloud development faster, more accurate, and cost-effective. https://github.com/awslabs/mcp

Hashtags

#python #aws #mcp #mcp_client #mcp_clients #mcp_host #mcp_server #mcp_servers #mcp_tools #modelcontextprotocol

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment